493 related articles for article (PubMed ID: 16730487)
1. Bone mineral density and depot medroxyprogesterone acetate.
Albertazzi P; Bottazzi M; Steel SA
Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
[TBL] [Abstract][Full Text] [Related]
2. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
Viola AS; Castro S; Bahamondes MV; Fernandes A; Viola CF; Bahamondes L
Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
Beksinska ME; Smit JA; Kleinschmidt I; Farley TM; Mbatha F
Contraception; 2005 Mar; 71(3):170-5. PubMed ID: 15722065
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
Clark MK; Sowers MR; Nichols S; Levy B
Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
[TBL] [Abstract][Full Text] [Related]
5. Depo Provera. Position paper on clinical use, effectiveness and side effects.
Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M
Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study.
Pongsatha S; Ekmahachai M; Chaovisitsaree S; Suntornlimsiri N; Morakote N
J Med Assoc Thai; 2009 Oct; 92(10):1263-7. PubMed ID: 19845231
[TBL] [Abstract][Full Text] [Related]
7. Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling.
Shaarawy M; El-Mallah SY; Seoudi S; Hassan M; Mohsen IA
Contraception; 2006 Oct; 74(4):297-302. PubMed ID: 16982229
[TBL] [Abstract][Full Text] [Related]
8. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections.
Harel Z; Johnson CC; Gold MA; Cromer B; Peterson E; Burkman R; Stager M; Brown R; Bruner A; Coupey S; Hertweck P; Bone H; Wolter K; Nelson A; Marshall S; Bachrach LK
Contraception; 2010 Apr; 81(4):281-91. PubMed ID: 20227543
[TBL] [Abstract][Full Text] [Related]
9. The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age.
Gai L; Zhang J; Zhang H; Gai P; Zhou L; Liu Y
Contraception; 2011 Mar; 83(3):218-22. PubMed ID: 21310282
[TBL] [Abstract][Full Text] [Related]
10. Depot medroxyprogesterone acetate use after peak bone mass is associated with increased bone turnover but no decrease in bone mineral density.
Walsh JS; Eastell R; Peel NF
Fertil Steril; 2010 Feb; 93(3):697-701. PubMed ID: 19013564
[TBL] [Abstract][Full Text] [Related]
11. The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women.
Scholes D; LaCroix AZ; Ichikawa LE; Barlow WE; Ott SM
Contraception; 2004 Feb; 69(2):99-104. PubMed ID: 14759613
[TBL] [Abstract][Full Text] [Related]
12. Long-term assessment of forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
Viola AS; Castro S; Marchi NM; Bahamondes MV; Viola CF; Bahamondes L
Contraception; 2011 Aug; 84(2):122-7. PubMed ID: 21757052
[TBL] [Abstract][Full Text] [Related]
13. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR
BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502
[TBL] [Abstract][Full Text] [Related]
14. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.
Scholes D; LaCroix AZ; Ichikawa LE; Barlow WE; Ott SM
Arch Pediatr Adolesc Med; 2005 Feb; 159(2):139-44. PubMed ID: 15699307
[TBL] [Abstract][Full Text] [Related]
15. Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
Sanches L; Marchi NM; Castro S; Juliato CT; Villarroel M; Bahamondes L
Contraception; 2008 Nov; 78(5):365-9. PubMed ID: 18929732
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
Kaunitz AM; Darney PD; Ross D; Wolter KD; Speroff L
Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
[TBL] [Abstract][Full Text] [Related]
17. Effects of hormonal contraception on bone mineral density after 24 months of use.
Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density and DMPA.
Westhoff C
J Reprod Med; 2002 Sep; 47(9 Suppl):795-9. PubMed ID: 12380409
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density, fracture, and vitamin D in adolescents and young women using depot medroxyprogesterone acetate.
Pitts SA; Feldman HA; Dorale A; Gordon CM
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):23-6. PubMed ID: 22078997
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate.
Clark MK; Sowers M; Levy B; Nichols S
Fertil Steril; 2006 Nov; 86(5):1466-74. PubMed ID: 16996507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
